{{Drugbox
| drug_name = 
| IUPAC_name        = 4-Amino-''N''-(2,6-dimethylphenyl)benzamide
| image             = Ameltolide.svg
| alt               = 
| caption           =

<!-- Clinical data -->
| tradename         = 
| Drugs.com         = 
| MedlinePlus       = 
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      = <!-- A / B            / C / D / X -->
| pregnancy_category= 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status      = 
| routes_of_administration =

<!-- Pharmacokinetic data -->
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| elimination_half-life = 
| excretion         =

<!-- Identifiers -->
| CAS_number        = 787-93-9
| ATCvet            = 
| ATC_prefix        = None
| ATC_suffix        = 
| PubChem           = 13086
| DrugBank          = 
| ChemSpiderID      = 12541

<!-- Chemical data -->
| C=15 | H=16 | N=2 | O=1
| molecular_weight  = 240.300 g/mol
| smiles = O=C(Nc1c(cccc1C)C)c2ccc(N)cc2
| StdInChI = 1S/C15H16N2O/c1-10-4-3-5-11(2)14(10)17-15(18)12-6-8-13(16)9-7-12/h3-9H,16H2,1-2H3,(H,17,18)
| StdInChIKey = HZIWGOAXOBPQGY-UHFFFAOYSA-N
}}

'''Ameltolide''', a 4-aminobenzamide [[derivative (chemistry)|derivative]], is an experimental [[anticonvulsant]] agent, effective at inhibiting [[seizures]] in [[animal model]]s.<ref>{{cite journal |doi=10.1021/jm00108a003 |title=Synthesis and pharmacological evaluation of a major metabolite of ameltolide, a potent anticonvulsant |year=1991 |last1=Robertson |first1=David W. |last2=Beedle |first2=E. E. |last3=Krushinski |first3=Joseph H. |last4=Lawson |first4=Ronald R. |last5=Parli |first5=C. John |last6=Potts |first6=Brian |last7=Leander |first7=J. David |journal=Journal of Medicinal Chemistry |volume=34 |issue=4 |pages=1253–7 |pmid=2016702}}</ref> It is non-toxic at dosing levels and no undesirable side effects are attributable to its application.<ref>{{cite journal |doi=10.1002/tera.1420440107 |title=Ameltolide. I: Developmental toxicology studies of a novel anticonvulsant |year=1991 |last1=Higdon |first1=Gary L. |last2=McKinley |first2=Edmund R. |last3=Markham |first3=Janet K. |journal=Teratology |volume=44 |pages=37–44 |pmid=1957261 |issue=1}}</ref>

==References==
{{reflist}}

[[Category:Anticonvulsants]]
[[Category:Benzanilides]]


{{nervous-system-drug-stub}}